Last reviewed · How we verify
NCT04083482
Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis
NA trial testing continous venovenous hemofiltraion in Intensive Care Unit in 20 participants. Status unknown.
20 September 2018
Quick facts
| Lead sponsor | First People's Hospital of Chenzhou |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 20 August 2018 |
| Primary completion | 20 September 2018 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- continous venovenous hemofiltraion
Conditions studied
- Intensive Care Unit — all drugs for Intensive Care Unit →
Sponsor
First People's Hospital of Chenzhou
Who can join
18 and older, any sex, with Intensive Care Unit. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The plasma level of mtDNA in sepsis is affected by continous venovenous hemofiltation（CVVH）
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04083482
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intensive Care Unit
Currently open trials in the same condition.
- NCT05451875 — Validation of Vital Signs Recording With VT-Patch Connected Devices in Children · recruiting
- NCT06556914 — Effect of Albumin Replacement on Oxygen Delivery in Sepsis Patients · recruiting
- NCT07200817 — Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Ou · recruiting
- NCT06481644 — Asia Pediatric Intensive Care Epidemiology and Outcomes Study · recruiting
- NCT06466811 — Prediction of Undesired Obstruction in External Ventricular Drains. · recruiting
Other First People's Hospital of Chenzhou trials
Trials by the same sponsor.
- NCT06237751 — Preoperative Sildenafil Administration for Hepatectomy · NA · recruiting
- NCT06254092 — Effect of Tourniquet Binding of Cervical on the Blood Volume of Amniotic Fluid in Cesarean Section · NA · unknown
- NCT05735132 — Novel Local Infiltration Anesthesia for Radial Artery Cannulation. · NA · unknown
- NCT05644535 — Cerebrospinal Fluid Gravity Correlation Analysis · unknown
- NCT05622656 — Dexmedetomidine Reduce Postoperative Pain of C-section · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04083482 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First People's Hospital of Chenzhou
- Last refreshed: 10 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04083482.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing